International Best Practices for Negotiating 'Reimbursement Contracts' With Price Rebates From Pharmaceutical Companies

Health Affairs - United States
doi 10.1377/hlthaff.2012.1268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Health Affairs (Project Hope)

Related search

Best Practices From the APDR

Academic Radiology
Nuclear MedicineRadiologyImaging
2018English

Integrating Variable Renewable Energy in Electric Power Markets. Best Practices From International Experience, Summary for Policymakers

2012English

Integrating Variable Renewable Energy in Electric Power Markets: Best Practices From International Experience, Summary for Policymakers

2012English

Small Pharmaceutical Companies

Organic Process Research and Development
Organic ChemistryTheoretical ChemistryPhysical
2004English

European Ex-Factory Price Development for Global Pharmaceutical Companies in the Context of the International Price Reference (Ipr) Framework. Impact of the German Health Care Reform (Amnog) on the European Price Development for Innovative Pharmaceuticals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Good Publication Practice for Pharmaceutical Companies

Current Medical Research and Opinion
Medicine
2003English

The Impact of Pharmaceutical Rebates on Patients’ Drug Expenditures

CMAJ
Medicine
2019English

What Do Pharmaceutical Companies Owe to Patients? Examining the (Un)ethical Aspects of the Pharmaceutical Industry's Practices

Turkish Journal of Bioethics
2015English

Best Practices for Dealing With Offshore Software Development

Handbook of Business Strategy
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy